Cerapedics’ i-FACTOR Demonstrates 98.6% Fusion Rate


Long-term follow-up data from a pivotal Investigational Device Exemption study of Cerapedics’ i-FACTOR Peptide-Enhanced Bone Graft demonstrated fusion rates of 98.6% in single-level Anterior Cervical Discectomy and Fusion (ACDF) after six years in patients treated with i-FACTOR.

i-FACTOR further demonstrated spine fusion rates of 89.7%, 97.3%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us